Clinical Trial Update: Post Marketing Surveillance of Roflumilast in Korea

View source ↗

Summary

Completed post-marketing surveillance study of roflumilast in Korea for chronic obstructive pulmonary disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Roflumilast (roflumilast)

Snippet

Sponsor: AstraZeneca | Conditions: Chronic Obstructive Pulmonary Disease | Status: COMPLETED